Capecitabine and irinotecan as first-line treatment of advanced colorectal cancer.
Punt
Cornelis J A
CJ
Koopman
Miriam
M
D000230:Adenocarcinoma / Q000188:drug therapy / Q000556:secondary*; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use*; D002166:Camptothecin / Q000008:administration & dosage / Q000009:adverse effects / Q000031:analogs & derivatives; D015179:Colorectal Neoplasms / Q000188:drug therapy* / Q000473:pathology; D003681:Dehydration / Q000139:chemically induced; D003841:Deoxycytidine / Q000008:administration & dosage / Q000009:adverse effects / Q000031:analogs & derivatives; D003967:Diarrhea / Q000139:chemically induced; D004334:Drug Administration Schedule; D005472:Fluorouracil / Q000008:administration & dosage / Q000009:adverse effects / Q000031:analogs & derivatives; D006801:Humans; D016032:Randomized Controlled Trials as Topic; D014839:Vomiting / Q000139:chemically induced
D003841:Deoxycytidine; D005472:Fluorouracil; D002166:Camptothecin